Sonic Healthcare Limited
SHL
Classificação em ações
#2841
Sonic Healthcare Limited delivers medical diagnostic services to a diverse... Sonic Healthcare Limited delivers medical diagnostic services to a diverse clientele, including medical professionals, hospitals, public health organizations, and individual patients. The company's services encompass a broad spectrum of laboratory medicine and pathology testing, covering biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal diagnostics, toxicology, and other related functions. Furthermore, Sonic provides extensive radiology services, such as magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. Its offerings also extend to primary care medical services, featuring general practice clinics, occupational health, specialized skin cancer clinics, after-hours GP services, IT solutions for general practices, and various community-based healthcare programs. Operating internationally, the company has a significant presence in Australia, the United Kingdom, Ireland, the United States, Germany, Switzerland, New Zealand, and Belgium. Founded in 1934, Sonic Healthcare Limited is headquartered in Sydney, Australia.
Preço da ação
$13.26
Valor de mercado
$6.55B
Variação (1 dia)
-0.21%
Variação (1 ano)
-4.48%
País
AU
Negociar Sonic Healthcare Limited (SHL)
Categoria
Healthcare
Rácio P/B de Sonic Healthcare Limited (SHL)
Rácio P/B em October 2026 TTM: 1.10
De acordo com os relatórios financeiros mais recentes e o preço das ações da Sonic Healthcare Limited, o rácio P/B atual (TTM) é 1.10. No final de 2024, o rácio P/B era 1.54.
Histórico do rácio P/B da Sonic Healthcare Limited de 2000 a 2026
Rácio P/B no final de cada ano
| Ano | Rácio P/B | Alterar |
|---|---|---|
| 2026 (TTM) | 1.10 | -29.31% |
| 2025 | 1.55 | 0.41% |
| 2024 | 1.54 | -28.56% |
| 2023 | 2.16 | -0.47% |
| 2022 | 2.17 | -24.41% |
| 2021 | 2.87 | 10.75% |
| 2020 | 2.59 | 15.19% |
| 2019 | 2.25 | -9.23% |
| 2018 | 2.48 | -5.93% |
| 2017 | 2.64 | 9.16% |
| 2016 | 2.41 | -7.84% |
| 2015 | 2.62 | 16.48% |
| 2014 | 2.25 | 13.87% |
| 2013 | 1.98 | 3.32% |
| 2012 | 1.91 | -3.84% |
| 2011 | 1.99 | 25.54% |
| 2010 | 1.58 | -10.98% |
| 2009 | 1.78 | -27.05% |
| 2008 | 2.44 | -22.67% |
| 2007 | 3.15 | -0.90% |
| 2006 | 3.18 | -17.65% |
| 2005 | 3.86 | 37.00% |
| 2004 | 2.82 | 39.04% |
| 2003 | 2.03 | 42.72% |
| 2002 | 1.42 | -45.74% |
| 2001 | 2.62 | -29.29% |
| 2000 | 3.71 | 0.00% |
Rácio P/B de empresas semelhantes ou concorrentes
| Empresa | Rácio P/B | Diferença do rácio P/B | País |
|---|---|---|---|
| 4.7411 | 332.70% |
US
|
|
| 3.0143 | 175.10% |
US
|
|
| 31.051 | 2,733.90% |
US
|
|
| - | - |
CN
|
|
| 6.6641 | 508.20% |
US
|
